Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Ongoing mini-HTAs in Norway in June 2024

In June 2024, the following ongoing mini-HTA assessments for cardiovascular, diagnostic imaging, e-health, endoscopy, gastrointestinal, in-vitro diagnostics, men’s health, neurology and neurosurgery, neuromodulation, peripheral vascular, pulmonary and airways, robotic surgery, and some other fields are evaluated as a part of a framework for the managed introduction of innovations "New Methods" in Norway. Some examples are listed below: 

  • Pulmonary vein isolation with Pulsed Field Ablation;
  • Robot-assisted ultrasound on pregnant women;
  • Use of the artificial intelligence application BoneView (by Gleamer) for analysis of diagnostic images in suspected fractures;
  • Breathe Better – A digital tool to strengthen the health skills of people with chronic lung disease;
  • Use of artificial intelligence (icobrain MS) for annotation and reporting of MS plaques and volumetry;
  • Transarterial radioembolization of liver tumors.

The full details in Norwegian can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.